en
Scientific article
Letter
English

Effects of elexacaftor-tezacaftor-ivacaftor discontinuation in cystic fibrosis

Published inRespiratory medicine and research, vol. 82, 100972
Publication date2022-11
First online date2022-11-02
Keywords
  • Adherence
  • Bronchiolitis
  • Elexacaftor–tezacaftor–ivacaftor
  • Withdrawal
  • Humans
  • Cystic Fibrosis / drug therapy
  • Cystic Fibrosis / genetics
  • Pyrazoles / adverse effects
Citation (ISO format)
MITROPOULOU, Georgia et al. Effects of elexacaftor-tezacaftor-ivacaftor discontinuation in cystic fibrosis. In: Respiratory medicine and research, 2022, vol. 82, p. 100972. doi: 10.1016/j.resmer.2022.100972
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal2590-0412
11views
0downloads

Technical informations

Creation01/09/2024 8:31:20 PM
First validation03/19/2024 8:40:12 AM
Update time03/19/2024 8:40:12 AM
Status update03/19/2024 8:40:12 AM
Last indexation03/19/2024 8:40:32 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack